OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Lipidology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial introductions	101
Genetic determinants of plasma lipids in Greenlanders	96
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease	73
Genetic variation in apolipoprotein A-V in hypertriglyceridemia	58
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?	39
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism	39
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review	33
Alveolar macrophages: guardians of the alveolar lipid galaxy	25
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?	23
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19	22
Oxidized LDL receptors: a recent update	22
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases	22
Exosomes and lipid metabolism in metabolic and cardiovascular disorders	21
Implementation science and genetic testing for familial hypercholesterolemia	21
Lipid metabolism during pregnancy: consequences for mother and child	21
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances	20
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?	19
Familial hypercholesterolemia in children and the importance of early treatment	18
Editorial introductions	17
Recent advances in understanding the spectrum of genetic determinants of lipoprotein(a) levels	16
Nonalcoholic fatty liver disease: an update	16
Genetic determinants of pancreatitis risk in hypertriglyceridemia	15
A new SPRING in lipid metabolism	15
The current state of apolipoprotein E in dyslipidemia	15
Editorial introductions	14

Familial hypercholesterolemia in pregnancy	14
Genetic insights from Greenland: when geography, history and genomics converge	14
APOE and familial hypercholesterolemia	14
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives	14
The need for national and international registries of patients with elevated lipoprotein(a)	14
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?	13
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?	13
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion	13
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets	13
From clinical development to real-world outcomes with inclisiran	13
Can small dense LDL cholesterol be estimated from the lipid profile?	12
Evolving guidelines on lipoprotein(a)	12
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent	12
Editorial introductions	11
In the wake of the Scandinavian Simvastatin Survival Study trial	11
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis	11
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis	10
Pregnancy, cardiovascular health, and microchimerism	10
Newborn screening for lipid disorders	10
Distinct roles of size-defined HDL subpopulations in cardiovascular disease	10
Cardiomyocytes, sphingolipids and cardio myotoxicity	10
Clinical associations between exercise and lipoproteins	9
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review	9
Strategies for management of patients with elevated lipoprotein(a)	9
Altered cardiovascular risk pattern of LDL cholesterol in older adults	9
Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis	9
Genetic testing for familial hypercholesterolemia	9
Dietary fat, telomere length and cognitive function: unravelling the complex relations	8
Navigating variants of uncertain significance in genetic dyslipidemia: how to assess and counsel patients	8
Prevention of cardiometabolic diseases through dietary modifications	8
A contemporary snapshot of familial hypercholesterolemia registries	8
Genotype–phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia	8
Lipidomics in gestational diabetes mellitus	8
The feedback cycles between glucose, amino acids and lipids and alpha cell secretion and their role in metabolic fatty liver disease	8
The pathophysiology of excess plasma-free cholesterol	8
Assessment of cardiovascular disease risk: a 2023 update	7
Recent lipoprotein(a) trials	7
How should low-density lipoprotein cholesterol be calculated in 2022?	7
Impact of mRNA and protein isoforms in lipoprotein metabolism and how to modulate them	7
HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?	7
Beyond cellular distress: reframing GDF15 as a lipid-sensitive metabolic signal	7
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events	7
Atherogenic low-density lipoprotein and cardiovascular risk	7
Editorial introductions	7
The current landscape of prospective proteomics research into dementia using blood-based samples	7
Predictors of cardiovascular risk in familial hypercholesterolemia	7
Diagnosis of remnant hyperlipidaemia	7
Triglyceride-rich lipoprotein cholesterol and cardiovascular risk	6
Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action	6
Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes?	6

Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges	6
Editorial introduction	6
Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations	6
Regulation of cardiovascular calcification by lipids and lipoproteins	6
Lipoprotein(a) in familial hypercholesterolemia	6
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism	6
Inflammation in atherosclerosis: a Big Idea that has underperformed so far	6
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future research	6
Genetics of remnant cholesterol	6
Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees	6
Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity	6
Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density	6
Editorial introduction	5
Emerging regulators of endothelial lipid metabolism in atherosclerosis	5
Orticumab: the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy	5
Bempedoic acid: new evidence and recommendations on use	5
Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery	5
Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives	5
Lipoprotein (a) in familial hypercholesterolaemia	4
PCSK9-directed therapies: an update	4
Ultra-processed foods and CKD: a review of evidence, limitations, and future directions	4
Editorial introductions	4
G protein-coupled receptor 146: new insights from genetics and model systems	4
Inflammation and atherosclerotic cardiovascular disease: where do we go from here?	4
Proprotein convertase subtilisin/kexin type 9 as a drug target for abdominal aortic aneurysm	4
Macrophage cannibalism: efferocytosis in atherosclerosis	4
Editorial introduction	4
Cycling of metabolic states and metabolites as drivers of atherosclerosis	4
Editorial introductions	4